3
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Incidence Rates and Cumulative Incidences of the Full Spectrum of Diagnosed Mental Disorders in Childhood and Adolescence

      research-article

      Read this article at

      ScienceOpenPublisherPMC
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          This nationwide cohort study estimates age- and sex-specific incidence rates and risks of being diagnosed with any mental disorder during childhood and adolescence using Danish population health registers.

          Key Points

          Question

          What are the age- and sex-specific incidence rates and cumulative incidences of the full spectrum of diagnosed mental disorders during childhood and adolescence?

          Findings

          In this nationwide cohort study of 1.3 million individuals in Denmark, the risk (cumulative incidence) of being diagnosed with a mental disorder before 18 years of age was 14.63% in girls and 15.51% in boys. Distinct age- and sex-specific patterns of occurrence were found across mental disorders in children and adolescents.

          Meaning

          These findings suggest that precise estimates of rates and risks of all mental disorders during childhood and adolescence are essential for future planning of services and care and for etiological research.

          Abstract

          Importance

          Knowledge about the epidemiology of mental disorders in children and adolescents is essential for research and planning of health services. Surveys can provide prevalence rates, whereas population-based registers are instrumental to obtain precise estimates of incidence rates and risks.

          Objective

          To estimate age- and sex-specific incidence rates and risks of being diagnosed with any mental disorder during childhood and adolescence.

          Design

          This cohort study included all individuals born in Denmark from January 1, 1995, through December 31, 2016 (1.3 million), and followed up from birth until December 31, 2016, or the date of death, emigration, disappearance, or diagnosis of 1 of the mental disorders examined (14.4 million person-years of follow-up). Data were analyzed from September 14, 2018, through June 11, 2019.

          Exposures

          Age and sex.

          Main Outcomes and Measures

          Incidence rates and cumulative incidences of all mental disorders according to the ICD-10 Classification of Mental and Behavioral Disorders: Diagnostic Criteria for Research, diagnosed before 18 years of age during the study period.

          Results

          A total of 99 926 individuals (15.01%; 95% CI, 14.98%-15.17%), including 41 350 girls (14.63%; 95% CI, 14.48%-14.77%) and 58 576 boys (15.51%; 95% CI, 15.18%-15.84%), were diagnosed with a mental disorder before 18 years of age. Anxiety disorder was the most common diagnosis in girls (7.85%; 95% CI, 7.74%-7.97%); attention-deficit/hyperactivity disorder (ADHD) was the most common in boys (5.90%; 95% CI, 5.76%-6.03%). Girls had a higher risk than boys of schizophrenia (0.76% [95% CI, 0.72%-0.80%] vs 0.48% [95% CI, 0.39%-0.59%]), obsessive-compulsive disorder (0.96% [95% CI, 0.92%-1.00%] vs 0.63% [95% CI, 0.56%-0.72%]), and mood disorders (2.54% [95% CI, 2.47%-2.61%] vs 1.10% [95% CI, 0.84%-1.21%]). Incidence peaked earlier in boys than girls in ADHD (8 vs 17 years of age), intellectual disability (5 vs 14 years of age), and other developmental disorders (5 vs 16 years of age). The overall risk of being diagnosed with a mental disorder before 6 years of age was 2.13% (95% CI, 2.11%-2.16%) and was higher in boys (2.78% [95% CI, 2.44%-3.15%]) than in girls (1.45% [95% CI, 1.42%-1.49%]).

          Conclusions and Relevance

          This nationwide population-based cohort study provides a first comprehensive assessment of the incidence and risks of mental disorders in childhood and adolescence. By 18 years of age, 15.01% of children and adolescents in this study were diagnosed with a mental disorder. The incidence of several neurodevelopmental disorders peaked in late adolescence in girls, suggesting possible delayed detection. The distinct signatures of the different mental disorders with respect to sex and age may have important implications for service planning and etiological research.

          Related collections

          Most cited references34

          • Record: found
          • Abstract: found
          • Article: not found

          Prevalence and treatment of mental disorders among US children in the 2001-2004 NHANES.

          This article presents the 12-month prevalence estimates of specific mental disorders, their social and demographic correlates, and service use patterns in children and adolescents from the National Health and Nutrition Examination Survey, a nationally representative probability sample of noninstitutionalized US civilians. The sample includes 3042 participants 8 to 15 years of age from cross-sectional surveys conducted from 2001 to 2004. Data on Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition criteria for mental disorders were derived from administration of selected modules of the National Institute of Mental Health Diagnostic Interview Schedule for Children, version IV, a structured diagnostic interview administered by lay interviewers to assess psychiatric diagnoses of children and adolescents. Twelve-month prevalence rates of Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition-defined disorders in this sample were 8.6% for attention-deficit/hyperactivity disorder, 3.7% for mood disorders, 2.1% for conduct disorder, 0.7% for panic disorder or generalized anxiety disorder, and 0.1% for eating disorders. Boys had 2.1 times greater prevalence of attention-deficit/hyperactivity disorder than girls, girls had twofold higher rates of mood disorders than boys, and there were no gender differences in the rates of anxiety disorders or conduct disorder. Only approximately one half of those with one of the disorders assessed had sought treatment with a mental health professional. These data constitute a first step in building a national database on mental health in children and adolescents.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Excess early mortality in schizophrenia.

            Schizophrenia is often referred to as one of the most severe mental disorders, primarily because of the very high mortality rates of those with the disorder. This article reviews the literature on excess early mortality in persons with schizophrenia and suggests reasons for the high mortality as well as possible ways to reduce it. Persons with schizophrenia have an exceptionally short life expectancy. High mortality is found in all age groups, resulting in a life expectancy of approximately 20 years below that of the general population. Evidence suggests that persons with schizophrenia may not have seen the same improvement in life expectancy as the general population during the past decades. Thus, the mortality gap not only persists but may actually have increased. The most urgent research agenda concerns primary candidates for modifiable risk factors contributing to this excess mortality, i.e., side effects of treatment and lifestyle factors, as well as sufficient prevention and treatment of physical comorbidity.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Mortality in children, adolescents, and adults with attention deficit hyperactivity disorder: a nationwide cohort study.

              Attention deficit hyperactivity disorder (ADHD) is a common mental disorder associated with factors that are likely to increase mortality, such as oppositional defiant disorder or conduct disorder, criminality, accidents, and substance misuse. However, whether ADHD itself is associated with increased mortality remains unknown. We aimed to assess ADHD-related mortality in a large cohort of Danish individuals.
                Bookmark

                Author and article information

                Journal
                JAMA Psychiatry
                JAMA Psychiatry
                JAMA Psychiatry
                JAMA Psychiatry
                American Medical Association
                2168-622X
                2168-6238
                20 November 2019
                February 2020
                20 November 2020
                : 77
                : 2
                : 155-164
                Affiliations
                [1 ]The Lundbeck Foundation Initiative for Integrative Psychiatric Research (iPSYCH), Aarhus, Denmark
                [2 ]National Centre for Register-Based Research, Department of Economics and Business Economics, Aarhus University, Aarhus, Denmark
                [3 ]Centre for Integrated Register-based Research, Aarhus University, Aarhus, Denmark
                [4 ]Geological Survey of Denmark and Greenland, Aarhus, Denmark
                [5 ]Department of Public Health, Aarhus University, Aarhus, Denmark
                [6 ]Queensland Centre for Mental Health Research, The Park Centre for Mental Health, Wacol, Australia
                [7 ]Queensland Brain Institute, University of Queensland, Brisbane, Australia
                Author notes
                Article Information
                Accepted for Publication: September 1, 2019.
                Corresponding Author: Søren Dalsgaard, MD, PhD, National Centre for Register-Based Research, Department of Economics and Business Economics, Aarhus University, Fuglesangs Allé 26, Bldg R, 8210 Aarhus V, Denmark ( sdalsgaard@ 123456econ.au.dk ).
                Published Online: November 20, 2019. doi:10.1001/jamapsychiatry.2019.3523
                Author Contributions: Ms Thorsteinsson and Dr Pedersen had full access to all the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis.
                Concept and design: Dalsgaard, McGrath, Pedersen.
                Acquisition, analysis, or interpretation of data: Dalsgaard, Thorsteinsson, Trabjerg, Schullehner, Plana-Ripoll, Brikell, Wimberley, Thygesen, Madsen, Timmerman, Schendel, Mortensen, Pedersen.
                Drafting of the manuscript: Dalsgaard.
                Critical revision of the manuscript for important intellectual content: Thorsteinsson, Trabjerg, Schullehner, Plana-Ripoll, Brikell, Wimberley, Thygesen, Madsen, Timmerman, Schendel, McGrath, Mortensen, Pedersen.
                Statistical analysis: Thorsteinsson, Plana-Ripoll, Wimberley, Pedersen.
                Obtained funding: Mortensen.
                Administrative, technical, or material support: Trabjerg, Madsen, Timmerman, Schendel, Mortensen, Pedersen.
                Supervision: Dalsgaard, Trabjerg, Schullehner, Wimberley, Pedersen.
                Conflict of Interest Disclosures: Dr Schullehner reported receiving grants from Aarhus University Research Foundation during the conduct of the study. Dr Mortensen reported receiving grants from the Lundbeck Foundation during the conduct of the study. No other disclosures were reported.
                Funding/Support: This study was supported by grants R102-A9118, R155-2014-1724, and R248-2017-2003 from the Lundbeck Foundation; grant AUFF-E-2015-FLS-8-61 from the Aarhus University Research Foundation (Dr Dalsgaard); grant NNF 22018 from the Novo Nordisk Foundation (Dr Dalsgaard); grant agreement No. 667302 from the European Union’s Horizon 2020 Research and Innovation Programme (Dr Dalsgaard; CoCA Study); grant R01-ES026993 from the National Institutes of Health (Dr Dalsgaard); grant 109399 from the Tryg Foundation (Dr Dalsgaard); grant 19-8-0260 from Helsefonden (Dr Dalsgaard); the Niels Bohr Professorship from the Danish National Research Foundation (Dr McGrath); John Cade Fellowship APP1056929 from National Health and Medical Research Council (Dr McGrath); the Stanley Medical Research Institute (Drs Mortensen and Pedersen); advanced grant 294838 from the European Research Council (Dr Pedersen); and Marie Sklodowska-Curie grant agreement 837180 from the European Union’s Horizon 2020 Research and Innovation Programme (Dr Plana-Ripoll).
                Role of the Funder/Sponsor: The sponsors had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.
                Article
                PMC6902162 PMC6902162 6902162 yoi190076
                10.1001/jamapsychiatry.2019.3523
                6902162
                31746968
                abdb21ef-59f6-4d30-8861-3bc812117a92
                Copyright 2019 American Medical Association. All Rights Reserved.
                History
                : 11 June 2019
                : 1 September 2019
                Categories
                Research
                Research
                Original Investigation
                Featured
                Online First
                Comments

                Comments

                Comment on this article